| Identification | More | [Name]
3,5-Dibromo-4-hydroxybenzoic acid | [CAS]
3337-62-0 | [Synonyms]
3',5'-DIBROMO-4-HYDROXYBENZOIC ACID
3,5-DIBROMO-4-HYDROXYBENZOIC ACID
4-HYDROXY-3,5-DIBROMOBENZOIC ACID
LABOTEST-BB LT00453976
RARECHEM AL BO 0009
TIMTEC-BB SBB006717
3,5-dibromo-4-hydroxy-benzoicaci
Benzoic acid, 3,5-dibromo-4-hydroxy-
Bromoxynylbenzoic acid
3,5-Dibromo-4-hydroxybenzoic acid, 98+%
Bromoxynilbenzoic acid | [EINECS(EC#)]
222-075-0 | [Molecular Formula]
C7H4Br2O3 | [MDL Number]
MFCD00002548 | [Molecular Weight]
295.91 | [MOL File]
3337-62-0.mol |
| Chemical Properties | Back Directory | [Appearance]
white fluffy fine crystalline powder | [Melting point ]
271-274 °C | [Boiling point ]
342.0±42.0 °C(Predicted) | [density ]
2.0591 (rough estimate) | [refractive index ]
1.4947 (estimate) | [storage temp. ]
Keep in dark place,Sealed in dry,Room Temperature | [solubility ]
DMSO (Sparingly), Methanol (Slightly) | [form ]
Solid | [pka]
3.79±0.10(Predicted) | [color ]
White to Off-White | [BRN ]
2416147 | [InChI]
InChI=1S/C7H4Br2O3/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,10H,(H,11,12) | [InChIKey]
PHWAJJWKNLWZGJ-UHFFFAOYSA-N | [SMILES]
C(O)(=O)C1=CC(Br)=C(O)C(Br)=C1 | [CAS DataBase Reference]
3337-62-0(CAS DataBase Reference) | [NIST Chemistry Reference]
3,5-Dibromo-4-hydroxybenzoic acid(3337-62-0) | [EPA Substance Registry System]
3337-62-0(EPA Substance) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi,C | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S24/25:Avoid contact with skin and eyes .
S37/39:Wear suitable gloves and eye/face protection .
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . | [Hazard Note ]
Irritant | [TSCA ]
Yes | [REACH Registrations]
Active | [HazardClass ]
IRRITANT | [HS Code ]
29163900 |
| Hazard Information | Back Directory | [Chemical Properties]
white fluffy fine crystalline powder | [Uses]
3,5-Dibromo-4-hydroxybenzoic Acid is an intermediate used to prepare benzbromarone (B185200) which is a uricosuric agent used in the treatment of gout and hyperuricemia. | [Definition]
ChEBI: A monohydroxybenzoic acid that is p-salicylic acid with bromo- substituents at C-3 and C-5 of the benzene ring. |
|
|